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The stem–loop binding protein (SLBP) is the posttranscriptional regulator of histone mRNA in metazoan cells.
SLBP binds histone pre-mRNAs and facilitates 3-end processing by promoting stable association of U7 snRNP
with the pre-mRNA. To identify other factors involved in histone pre-mRNA processing, we used a modified
yeast two-hybrid assay in which SLBP and its RNA target were coexpressed as bait. A novel zinc finger
protein, hZFP100, which interacts with the SLBP/RNA complex but not with free SLBP, was cloned. The
interaction requires regions of SLBP that are important for histone pre-mRNA processing. Antibodies to
hZFP100 precipitate U7 snRNA, and expression of hZFP100 in Xenopus oocytes stimulates processing of
histone pre-mRNA, showing that hZFP100 is a component of the processing machinery.
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In metazoans replication-dependent histone mRNAs are
not polyadenylated but instead terminate with a highly
conserved stem–loop structure, consisting of 6 bp and a
4-nt loop (Marzluff 1992). The replication-dependent his-
tone mRNAs are formed from longer pre-mRNA tran-
scripts by endonucleolytic cleavage 4–5 nt downstream
from the stem–loop (Gick et al. 1986; Dominski and
Marzluff 1999). This 3-end processing reaction requires
at least two trans-acting factors: (1) the stem–loop bind-
ing protein, SLBP (Wang et al. 1996a), also known as the
hairpin binding protein (Martin et al. 1997), which asso-
ciates with the stem–loop structure (SL); and (2) U7
snRNP, which recognizes a purine-rich sequence, the
histone downstream element (HDE), located ∼10 nt
downstream from the cleavage site (Strub et al. 1984;
Georgiev and Birnstiel 1985; Mowry and Steitz 1987a).
Human SLBP is a 31-kD protein containing 270 amino
acids and is composed of three domains, the centrally
located RNA-binding domain (RBD) and its flanking N-
terminal and C-terminal domains (Wang et al. 1996a).
The RBD, which is unique among all known RNA-bind-
ing proteins, mediates binding of SLBP to the stem–loop
structure (Wang et al. 1996a; Martin et al. 2000; Domin-
ski et al. 2001). The U7 snRNP is a minor snRNP, rep-
resented in an average mammalian cell by ∼103–104 par-
ticles (Birnstiel and Schaufele 1988; Smith et al. 1991;
Grimm et al. 1993). The human U7 snRNP contains the
63-nt U7 snRNA (Mowry and Steitz 1987b) and associ-
ated proteins, including a set of Sm proteins and at least
two additional U7-specific proteins (Smith et al. 1991;
Stefanovic et al. 1995; Pillai et al. 2001). Binding of U7
snRNP to the pre-mRNA occurs primarily via base pair-
ing between the HDE and the 5 end of U7 snRNA
(Schaufele et al. 1986; Bond et al. 1991). Additional fac-
tors involved in 3-end processing of histone pre-
mRNAs, including the factor(s) responsible for cata-
lyzing the cleavage reaction, have not yet been identi-
fied. After the completion of 3-end processing, SLBP
remains associated with the terminal stem–loop and as-
sists the mature histone mRNA to the cytoplasm, where
it possibly regulates histone mRNA translation (Sun et
al. 1992; Gallie et al. 1996) and stability (Pandey and
Marzluff 1987). The efficiency of 3-end processing of
replication-dependent histone pre-mRNAs is cell cycle
regulated and reaches a peak level during the S phase,
followed by a rapid decline on completion of DNA rep-
lication (Stauber and Schümperli 1988; Harris et al.
1991). The high efficiency of 3-end processing resumes
at the end of G1 phase, prior to the next round of DNA
replication. Restricting the 3-end processing of histone
pre-mRNA to the S phase is at least in part achieved by
cell cycle regulation of SLBP, which accumulates to high
levels only during S phase and is degraded through the
proteasome pathway at the completion of S phase (Whit-
field et al. 2000).
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The HDE sequence varies considerably among the 60
different mammalian replication-dependent histone pre-
mRNAs (Wang et al. 1996b). Because there is only a
single U7 snRNA gene in mammalian cells (Gruber et al.
1991; Turner et al. 1996), binding of U7 snRNP to the
pre-mRNA mediated by base-pairing does not result in
formation of a sufficiently stable complex for efficient
3-end processing of most histone pre-mRNAs. SLBP as-
sociated with the pre-mRNA stabilizes the binding of U7
snRNP, suggesting that SLBP bound to the pre-mRNA
might interact with one of the U7 snRNP specific pro-
teins (Dominski et al. 1999). In support of this, even a
small increase in the distance between the stem–loop
structure and the HDE results in a rapid decline in pro-
cessing efficiency (Scharl and Steitz 1994, 1996), most
likely by preventing productive interaction between
SLBP and U7 snRNP, bound to their respective sites on
the pre-mRNA (Dominski et al. 1999). This additional
interaction is critical in processing of histone pre-
mRNAs, for example, mouse histone H1t pre-mRNA,
that contain an HDE capable of forming only a weak
duplex with the U7 snRNA (Dominski et al. 1999). Con-
versely, pre-mRNA substrates such as mouse H2a-614
pre-mRNA, which contain an HDE that forms a nearly
perfect duplex with U7 snRNA, can be processed in vitro
with a modest efficiency even in the absence of SLBP
(Melin et al. 1992; Streit et al. 1993; Spycher et al. 1994;
Dominski et al. 1999).
To date, SLBP remains the only factor specifically in-
volved in histone pre-mRNA 3-end processing that is
available for both biochemical and genetic studies. Here
we describe an RNA-supplemented yeast two-hybrid
screen used for the identification of human proteins in-
teracting with the SLBP/SL complex. This modified ver-
sion of the yeast two-hybrid system, in which SLBP
fused to the GAL4 DNA-binding domain is coexpressed
with the stem–loop RNA, allowed cloning of a new fac-
tor involved in histone pre-mRNA 3-end processing.
This factor, designated hZFP100, has an estimated mo-
lecular mass of 100 kD and contains 18 C2H2 zinc fin-
gers. hZFP100 is associated with the U7 snRNP in
nuclear extracts from HeLa cells. Moreover, when
hZFP100 is expressed in Xenopus oocytes, it stimulates
3-end processing of the histone pre-mRNA transcribed
from the exogenous mouse H2a-614 histone gene. The
RNA-supplemented yeast two-hybrid system may be a
valuable general method for identifying proteins inter-
acting with complexes of other known RNA-binding
proteins and their respective RNA targets.
Results
Screening of a HeLa cDNA library for proteins
interacting with the SLBP/SL RNA complex
SLBP stimulates 3-end processing by stabilizing the as-
sociation of U7 snRNP with the pre-mRNA substrate
(Melin et al. 1992; Streit et al. 1993; Spycher et al. 1994;
Dominski et al. 1999). This might be achieved by a direct
interaction between SLBP tightly bound to the stem–
loop structure and a protein stably or transiently associ-
ated with the U7 snRNP. The yeast two-hybrid system is
routinely used for the cloning of proteins that interact in
vivo with a previously cloned protein of interest (Chien
et al. 1991). Here, we used a modification of this system
for identifying a component of the U7 snRNP that interacts
with SLBP during 3-end processing of histone pre-mRNA.
Because the C-terminal region of SLBP contains se-
quences that result in self-activation in the two-hybrid
system (L.-X. Zheng and W.F.M., unpubl.), we tested de-
letions of the C terminus for their ability to process his-
tone pre-mRNA and to self-activate the reporter genes in
the two-hybrid system. The sequence of the RBD and the
C-terminal domain of SLBP with the mutations used is
shown in Figure 1A. A nuclear extract depleted of SLBP
is inactive in H1t histone pre-mRNA processing, and the
control level of processing efficiency can be restored by
addition of recombinant SLBP expressed in baculovirus
(Fig. 1B, lanes 1–3; Dominski et al. 1999, 2001). Deletion
of 41 amino acids from the C terminus (C41) reduced
processing efficiency ∼25% (Fig. 1B, lane 5), whereas de-
letion of the last 27 amino acids (C27) had no effect on
processing efficiency (Fig. 1B, lane 4). In addition, the
C27 mutant SLBP no longer self-activated the HIS3 re-
porter gene and was consequently selected as bait for the
yeast two-hybrid screen.
Figure 1. Human SLBP lacking the last 27 amino acids is fully
active in 3-end processing. (A) The sequence of the human
SLBP RBD (underlined) and C-terminal domain is shown. The
break points of the C-terminal deletions are indicated by ar-
rows. The 9aaR and 20aaC SLBP mutants contain substitutions
of the residues highlighted in the RBD and in the region C-
terminal to the RBD, respectively. (B) Histone H1t pre-mRNA
labeled at the 5 end with 32PO4 was incubated at 32°C for 30
min in a nuclear extract prepared from mouse myeloma cells.
The RNA was isolated, resolved by gel electrophoresis, and de-
tected by autoradiography. Shown is the processing activity of
(lane 1) control and (lane 2) SLBP-depleted nuclear extracts.
(Lanes 3–7) The ability of 100 ng of different baculovirus-ex-
pressed SLBPs (indicated at the top of each lane) to restore his-
tone pre-mRNA processing to the depleted nuclear extract.
(WT) Wild type. Unproc and Proc indicate the input H1t pre-
mRNA and mature product of 3-end processing, respectively.
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To select for proteins that bound to the SLBP/RNA
complex rather than free SLBP, the yeast two-hybrid
system was modified by introduction of a hybrid RNA
containing the stem–loop structure (Fig. 2A; Wang et
al. 1996a). The pGBT/SLBP/SLWT plasmid, which ex-
presses both C27 SLBP and an RNA containing the
stem–loop, was introduced into the CG-1945 yeast re-
porter strain. This strain harboring the pGBT/SLBP/
SLWT plasmid was used to screen a GAL4 AD/HeLa
cDNA fusion library constructed in the pGAD GH vec-
tor (Clontech). We carried out four independent transfor-
mations with the cDNA library, each time systemati-
cally increasing the concentration of 3-AT in the me-
dium (from 0 to 5.0 mM). The higher stringency of
selection in the presence of 3-AT resulted in a drastic
reduction in the number of colonies that grew on plates
lacking histidine.
Only two unknown proteins were represented among
>150 cDNA inserts analyzed in detail: a putative 36-kD
protein (GenBank accession no. AF132946) with no simi-
larity to any sequence available in the Swissprot data-
base, and a 100-kD member of the zinc finger protein
family, designated hZFP100 (see Fig. 4 below). The 36-
kD protein was selected twice, in both cases only in the
absence of 3-AT, but hZFP100 was repeatedly isolated in
all four screens and represented ∼50% of the clones se-
lected from the plates containing 2.5 mM 3-AT. Two
ribosomal proteins, S15a and L22, were selected multiple
times in the absence of 3-AT. Altogether, from more
than 15 million transformants analyzed in multiple
screens, hZFP100 was selected 25 times.
hZFP100 interacts with the SLBP/SL complex
but not with SLBP alone
We tested whether hZFP100 interacts only with the
SLBP/SL complex or whether the interaction can also
occur in the absence of the stem–loop RNA, by trans-
forming the hZFP100 into yeast expressing just the
SLBP. The yeast cells expressing hZFP100, SLBP, and
stem–loop RNA efficiently grew on medium containing
50 mM 3-AT (Fig. 2B, lane 2), but in the absence of the
stem–loop RNA, growth was abolished by 2.5 mM 3-AT
(Fig. 2B, lane 5), indicating that hZFP100 interacts very
weakly, if at all, with free SLBP. The second reporter
gene under control of the GAL4-binding site, LacZ, was
also strongly activated by hZFP100 only in the presence
of both SLBP and the histone stem–loop RNA (Fig. 2B,
lane 3). In the absence of the RNA, the yeast cells re-
mained white or turned only light blue (Fig. 2B, lane 6).
A similar profile of activation of both reporter genes in
the presence and absence of SL RNA was observed with
two other clones: clone 8 (the unknown 36-kD protein)
and clone 22 (ribosomal protein S15a; Fig. 2B).
The absolute requirement for the RNA component in
the interaction between SLBP and hZFP100 could result
from direct interaction between hZFP100 and the SLBP
in the SLBP/RNA complex or from formation of a com-
plex in which the two proteins bind independently to the
bridging RNA containing the stem–loop. In the latter
case, SLBP would recognize the stem–loop, whereas
hZFP100 would interact with another portion of the
RNA. Formation of such a complex is utilized in the
Figure 2. The RNA-supplemented two-hybrid system. (A) The DNA-binding-domain hybrid is composed of the GAL4 DNA binding
domain (DBD) fused to the C27 mutant of human SLBP. The RNA component contains the RNase P leader at the 5 end and two
MS2-binding sites in the center, followed by the histone stem–loop. In the diagram only one MS2-binding site is depicted, and the
RNase P leader is omitted. Protein X fused to the GAL4 activation domain (AD) interacts with the SLBP/RNA complex. The
interaction brings the GAL4 AD into proximity to the promoter, resulting in activation of the HIS3 and LacZ reporter genes controlled
by the GAL4-binding site. (B) Clones isolated in the RNA-supplemented two-hybrid system interact with the SLBP/SL complex but
not with SLBP. Expression of two reporter genes, HIS3 and LacZ, was determined by testing the ability of yeast cells to grow on
selective medium and by assaying -galactosidase activity. To determine expression of the HIS3 gene, a suspension of yeast containing
the library plasmid pGAD GH with the indicated cDNA insert, and the bait plasmid expressing SLBP with (left, lanes 1–3) or without
stem–loop RNA (right, lanes 4–6), was spotted on medium with histidine (lanes 1,4) and on medium lacking histidine containing 10
mM 3-AT (lanes 2,5). hZFP100 and two other clones (8 and 22) isolated by the RNA-supplemented two-hybrid system are shown.
Clone 8 is a putative 36-kD protein and clone 22 is ribosomal protein S15a. The ability of each clone to interact with the SLBP/RNA
complex (lane 3) and free SLBP (lane 6) was confirmed by analysis of expression of the LacZ gene using a qualitative blue/white assay.
After a 2-h incubation, cell suspensions were spotted on a white background and photographed. (C) The hSLBP was replaced in the bait
construct shown in A with the Drosophila SLBP, and the ability of the three clones isolated in the initial screen to grow in the presence
of 10 mM 3-AT was determined.
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three-hybrid system, designed for cloning RNA-binding
proteins, and does not require any direct contact be-
tween the two proteins (SenGupta et al. 1996). We tested
this possibility by replacing human SLBP used as bait in
the screening procedure with the recently cloned Dro-
sophila homolog dSLBP, which is similar to the human
protein only in the RBD (Sullivan et al. 2001). The RBD
of dSLBP cannot substitute for the RBD of human SLBP
in histone 3-end processing (Z. Dominski and W.F. Mar-
zluff, unpubl.). Expression of hZFP100 in yeast express-
ing dSLBP and the stem–loop RNA did not allow growth
of the yeast in the presence of 10 mM and higher con-
centrations of 3-AT (Fig. 2C, bottom, lane 1). In contrast,
expression of clone 22 did support growth (Fig. 2C, bot-
tom, lane 3) suggesting that it may form a bridging RNA
complex (and not interact directly with SLBP) or interact
with some region of SLBP common to the Drosophila
and human proteins. hZFP100 also interacted very
weakly and nonspecifically with the RNA bait alone in
the standard three-hybrid assay (data not shown). These
results strongly support the argument that hZFP100 di-
rectly interacts with SLBP associated with the stem–loop
RNA.
Mapping the regions of SLBP interacting with hZFP100
We have previously established that the entire N-termi-
nal domain of SLBP consisting of 127 amino acids is
dispensable for the activity of SLBP in 3-end processing
in vitro. The region absolutely essential for processing of
H1t pre-mRNA is the RBD plus the first 20 amino acids
immediately following the RBD (Dominski et al. 1999).
To determine which regions of SLBP mediate its inter-
action with hZFP100, we replaced the C27 SLBP bait
with various mutant SLBPs (Fig. 3A) and tested expres-
sion of both HIS3 (Fig. 3B) and LacZ (data not shown)
reporter genes. Removal of the 127-amino-acid N-termi-
nal domain from SLBP (N) had no effect on the inter-
action with hZFP100 (Fig. 3B, bottom, lane 3), whereas
deletion of the entire C terminus, leaving only the RBD,
eliminated expression of the HIS3 reporter gene (Fig. 3B,
bottom, lane 6).
The RBD itself plays a dual role in processing: first, it
mediates binding of SLBP to the stem–loop structure in
the pre-mRNA; and second, it provides a number of resi-
dues involved in an additional interaction within the
processing complex (Ingledue et al. 2000; Dominski et al.
2001). We have previously described mutations in the
RBD (Dominski et al. 2001) and in the 20 amino acids
C-terminal to the RBD (Dominski et al. 1999) that affect
processing and recruitment of U7 snRNP without affect-
ing RNA binding. Two of these mutants, 9aaR and
20aaC (shown in Fig. 1A,B, lanes 6,7), were used to iden-
tify clones that interact with regions of SLBP required for
processing. When tested for their ability to interact with
hZFP100, each of these mutants greatly reduced expres-
sion of the HIS3 gene (Fig. 3B, bottom, lanes 4,5) and had
a similar effect on expression of the LacZ gene (data not
shown). Clone 8, which was similar to hZFP100 in all
the other tests for interaction with SLBP, did not interact
with 20aaC SLBP, but, unlike hZFP100, did interact with
9aaR (data not shown). We conclude that the interaction
of hZFP100 with the SLBP/SL complex depends on re-
gions of SLBP that play an important role in 3-end pro-
cessing of histone pre-mRNA.
hZFP100 contains 18 zinc fingers of the C2H2 type
The 3.8-kb cDNA insert encoding hZFP100 predicts an
871-amino-acid protein with a calculated molecular
mass of 101 kD. All yeast transformants expressing
hZFP100 contained the identical cDNA insert (GenBank
accession no. AF454744), indicating that they originated
from the same clone. Only two partial ESTs (GenBank
accession nos. AB032967 and AL080143) for hZFP100
were present in the human EST database, showing that
the mRNA encoding hZFP100 is in very low abundance
in the cell. The gene encoding hZFP100 is located in
position 19q13.33 on Chromosome 19 and has not pre-
viously been annotated. The predicted gene structure has
Figure 3. hZFP100 does not interact with mutant SLBPs de-
fective in histone pre-mRNA processing. (A) Diagram of the
wild-type (WT) SLBP and five mutants containing specific alter-
ations within different parts of the protein: N-terminal and C-
terminal flanking domains (N-ter and C-ter, respectively) and
the central RBD. The gray boxes in the 9aaR and 20aaC mutants
represent the 9-amino-acid substitution in the RBD and the
20-amino-acid substitution in the C terminus shown in Figure
1A, respectively. Both mutations abolish in vitro processing of
the H1t pre-mRNA without affecting binding to the stem–loop
structure. The ability of each mutant SLBP to restore 3-end
processing to the SLBP-depleted nuclear extract (expressed as a
percentage of the wild-type SLBP) and to bind the stem–loop
RNA is shown to the right. (B) The effect of the SLBP mutations
shown in A on the interaction with hZFP100 was determined by
the ability of yeast cells to grow on medium lacking histidine
and containing 10 mM 3-AT (bottom row). (Lanes 1,2) The
strength of the interaction between SLBP C27 and hZFP100
without and with coexpression of the SL RNA, respectively.
SLBPs lacking the N terminus (N, lane 3) and the processing-
defective SLBPs 9aaR and 20aaC, and the SLBP RBD (lanes 4–6)
were also assayed for the ability to interact with hZFP100 in the
presence of the stem–loop RNA.
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Figure 4. hZFP100 is a novel 100-kD protein containing 18 C2H2
zinc fingers. (A) Amino acid sequence (1–871) of hZFP100 and
nucleotide sequence of the 5 and 3 untranslated regions (UTRs).
The nucleotide sequence in capital letters represents genomic se-
quence located immediately upstream of the first nucleotide of the
cloned cDNA (in small letters), retrieved from the NCBI human
genome database. The first in-frame Stop codon at the 5 end of the
clones is indicated with stars, and a presumptive TATAA box is
boxed. The zinc fingers are underlined and numbered from 1 to 18,
and the N-terminal region with a limited homology to KRAB is in-
dicated with a thick line. The polyadenylation signal in the 3 UTR
is double underlined. (B) The 18 zinc fingers of hZFP100 are aligned
with the conserved C and H residues involved in chelating the zinc
ions and the conserved F and L residues indicated by arrows.
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4 exons, with the last exon encoding 80% of the protein.
The sequence of the remainder of the 3 UTR not present
in the two-hybrid clone, consisting of 392 nucleotides,
was retrieved from the database of human ESTs (Gen-
Bank accession no. AL080143). It contains a noncanoni-
cal polyadenylation signal AUUAAA, located 11 nt up-
stream from the site of the poly(A) addition (double un-
derlined in Fig. 4A). The clone we isolated contained 192
nt of 5 UTR that was in frame with hZFP100. Because
the 5 UTR did not contain any Stop codon in frame with
the open reading frame (as expected for all inserts se-
lected in the two-hybrid system), it was possible that the
available cDNA represented only a partial hZFP100
mRNA lacking the bona fide initiation codon and that
the actual protein is significantly larger than initially
estimated. Inspection of the genomic sequence immedi-
ately preceding the sequence of the cDNA reveals a
TATAA sequence (boxed in Fig. 4A) ∼25 nt upstream of
the 5 end of the clone and an adjacent in-frame Stop
codon (starred in Fig. 4A). No ATG codons or obvious 3
splice junctions were present in this region. We conclude
from this analysis that the available cDNA represents
close to the full-length hZFP100 mRNA, and the ATG
codon at position 193 of the cDNA represents the start of
translation. In support of this interpretation, the sizes of
the hZFP100 produced by in vitro translation and of the
protein precipitated by the anti-Sm antibody are identi-
cal (see Fig. 7A below).
Inspection of the 871-amino-acid protein identified 18
zinc fingers of the C2H2 type fully conforming to the
known consensus sequence (Fig. 4B). Each C2H2 zinc
finger contains 21 amino acids with two conserved cys-
teines and histidines that coordinate binding of a zinc
ion, as well as conserved phenylalanine and leucine resi-
dues at positions 8 and 14, respectively (Berg and Shi
1996). The first zinc finger is located between amino
acids 211 and 231 and is separated from the next one by
90 amino acids. Zinc fingers 2–4, 5–8, 9–10, and 11–18
are clustered together, and each finger in the cluster is
separated by 7 amino acids. Three of these interfinger
spacers, referred to as H/C links, located in the C-termi-
nal portion of hZFP100, contain the highly conserved
sequence TGEKPY, found in nearly half of the known
C2H2 zinc finger proteins that bind DNA (Laity et al.
2001). In addition to 18 typical zinc fingers, hZFP100
contains a number of degenerate zinc fingers with either
deletions or substitutions of single conserved amino ac-
ids. At the N terminus of hZFP100 there is a weakly
conserved element, identified in a number of proteins
related to the Krüppel transcription factor, termed Krüp-
pel-associated box, or KRAB (Laity et al. 2001). The pos-
sible KRAB element found in hZFP100 is shorter than
the classical KRAB by ∼30 amino acids and is only 43%
identical with KRAB.
Zinc fingers 2–8 interact with the SLBP/SL complex
We prepared a series of deletions to delineate the region
of hZFP100 that interacts with the SLBP/SL complex.
Deleting 15 (C15) and 256 (C256) amino acids from
the C terminus of hZFP100, encompassing one and eight
zinc fingers, respectively, did not significantly reduce
the ability of yeast cells to grow on selective medium
containing 10 mM 3-AT (Fig. 5A, bottom, lanes 4,5). De-
letion of an additional 104 amino acids encompassing
three zinc fingers (C360) weakened the interaction be-
tween hZFP100 and the SLBP/SL complex, whereas re-
moval of the next 73 amino acids (C439) virtually abol-
Figure 5. hZFP100 interacts with the SLBP/SL RNA complex through zinc fingers 2–8. (A) Yeast expressing the SLBP/SL complex
were transformed with the various deletion mutants of hZFP100 indicated at the top of each column. The ability of the mutants to
interact with the SLBP/SL complex was determined by plating yeast cells on medium with 10 mM 3-AT (bottom row). (Top row) The
control rate of yeast growth on medium containing histidine (no selection applied). Wild type (WT) represents the original hZFP100
clone isolated from the screen. This clone encodes the 871-amino acid hZFP100 extended at the N terminus by an additional 64 amino
acids generated by translation of the 5 UTR. The 5UTR clone encodes the full-length hZFP100. (B) The amino acid sequence of
hZFP100 from 312 to 628 is shown with the zinc fingers underlined. The solid arrowheads indicate break points of the C-terminal
deletions. (C) The minimal region of hZFP100 required for efficient interaction with the SLBP/SL complex. Four overlapping portions
of the cDNA for hZFP100 were amplified by PCR and cloned in-frame downstream of the region encoding the GAL4 AD. The lengths
of the truncated proteins and the regions they span in the full-length hZFP100 are indicated to the right. Each of the four regions of
hZFP100 were tested for interaction with the SLBP/SL complex, as in A.
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ished the interaction (Fig. 5A, bottom, lanes 6,7). No
change in the strength of interaction with the SLBP/SL
complex was observed after deleting the 64 amino acids
encoded by the 5 UTR of hZFP100 (5UTR; Fig. 5A,
bottom, lane 2) or the first 168 amino acids of hZFP100
(N168; Fig. 5A, bottom, lane 3). These experiments nar-
rowed down the region of hZFP100 interacting with the
complex of SLBP and SL RNA to 448 amino acids (168–
615).
To further define the region required for interaction
with SLBP, a series of overlapping subclones was con-
structed and analyzed. Subclones containing residues
312–628 (zinc fingers 2–10) and 312–552 (zinc fingers
2–8) interacted strongly with the SLBP/SL complex (Fig.
5C, rows 1,2). The subclone 416–628, which removed
zinc fingers 2–4, had significantly reduced binding (Fig.
5C, row 3). Because a protein containing amino acids
1–511 also bound weakly (C360; Fig. 5A, bottom, lane
6), this defines a C-terminal boundary of the region re-
quired for binding between amino acids 511 and 552. A
protein (amino acids 416–552) containing just zinc fin-
gers 5–8 did not interact with SLBP (Fig. 5C, row 4). From
analysis of both the deletion mutants and the minigenes,
we conclude that the critical region of hZFP100 inter-
acting with the SLBP/SL complex is located in the cen-
tral part of the protein, between amino acids 312 and
552, and contains zinc fingers 2–8.
Immunoprecipitation of U7 snRNP by the hZFP100
antibody
The antibody raised against a peptide containing the C-
terminal 18 amino acids of hZFP100 immunoprecipi-
tated the 35S-labeled protein expressed in the rabbit re-
ticulocyte extract (Fig. 6A, lane 1). The efficiency of pre-
cipitation of hZFP100 from the reticulocyte lysate varied
between 30% and 50%, depending on the batch of affin-
ity-purified antibody used. Binding of the antibody to the
zinc finger protein was completely inhibited by the pep-
tide used for immunization but not by a nonspecific pep-
tide (Fig. 6A, lanes 2 and 3, respectively). Unrelated an-
tibodies, including the anti-SLBP antibody (Fig. 6A, lane
4), did not precipitate the hZFP100.
To determine whether hZFP100 is associated with the
U7 snRNP we tested the ability of the antibody to
hZFP100 to precipitate U7 snRNA. We incubated a con-
stant amount of a nuclear extract from HeLa cells with
increasing amounts of the anti-hZFP100, prepared RNA
from the immunoprecipitates, and assayed for the pres-
ence of U7 snRNA by Northern blotting. As a control the
immunoprecipitates were analyzed for the presence of
U2 and U1 (data not shown). Increasing amounts of the
anti-hZFP100 precipitated increasing amounts of U7
snRNA (Fig. 6B, top, lanes 5–7), and 20%–25% of the U7
snRNA in the nuclear extract was precipitated by the
highest concentration of the antibody. Other prepara-
tions of affinity-purified anti-hZFP100 were able to re-
move as much as 40% of U7 snRNA from the nuclear
extract. Further increasing the concentration of the an-
tibody in the nuclear extract or repeated incubation of
the supernatant with a second aliquot of antibody did
not result in precipitation of additional U7 snRNA (data
not shown). Precipitation of the U7 snRNP by the anti-
hZFP100 was blocked by the antigenic peptide (data not
shown). Under the same conditions, U1 snRNA (data not
shown) and U2 snRNA were detected only at back-
ground levels (Fig. 6B, bottom, lanes 5–7), similar to the
amount of these snRNAs bound to the beads in the ab-
sence of antibody (Fig. 6B, bottom, lane 1).
The mouse monoclonal antibody Y-12 recognizes an
epitope on the Sm proteins that are present in the nu-
cleoplasmic snRNPs, including U7 snRNP (Strub and
Birnstiel 1986; Mowry and Steitz 1987b). We tested this
antibody in parallel with the anti-hZFP100 for its ability
to precipitate U7 snRNA. The anti-Sm antibody precipi-
tated similar amounts of the U7 snRNP as the anti-
hZFP100 antibody (Fig. 6B, top, lanes 2–4). It also pre-
cipitated the U2 snRNA (Fig. 6B, bottom, lanes 2–4) and
U1 snRNA (data not shown). The intensity of the band
corresponding to the synthetic U7 snRNA (Cont), added
to the immunoprecipitates to control for RNA recovery,
was similar in all samples.
Anti-Sm immunoprecipitate is enriched in hZFP100
The anti-hZFP100 readily detected the in vitro synthe-
sized hZFP100 in a Western blot assay (Fig. 7A, lane 1).
The same preparation of the antibody barely detected
Figure 6. The anti-hZFP100 antibody precipitates U7
snRNA. (A) hZFP100 was synthesized in a rabbit reticu-
locyte lysate in the presence of 35S methionine. The ly-
sate was treated with anti-hZFP100 in the absence (lane
1) or presence (lane 2) of the antigenic peptide, in the
presence of a nonspecific peptide (lane 3), or with anti-
SLBP (lane 4). The proteins were resolved by electropho-
resis in a 12% SDS-polyacrylamide gel and detected by
autoradiography. (B) A nuclear extract from HeLa cells
was incubated with increasing amounts of anti-Sm (5–25
µg; lanes 2–4) or anti-hZFP100 (1–5 µg; lanes 5–7) anti-
body. RNA was prepared from the immunoprecipitates
and analyzed by Northern blotting for U7 snRNA (top) or
U2 snRNA (bottom). Lane 1 shows the snRNA bound to the beads in the absence of antibody. Cont represents a synthetic RNA
containing the U7 snRNA sequence (Dominski et al. 1999), used as a control for precipitation and hybridization.
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hZFP100 in a HeLa nuclear extract (Fig. 7A, lane 2), in-
dicating that there are very small amounts of the protein
in the extract. In addition to detecting hZFP100, the
anti-hZFP100 also detected a number of relatively abun-
dant proteins of lower molecular weight (Fig. 7A, lane 2).
To determine whether hZFP100 was present in snRNPs,
the nuclear extract was precipitated with the anti-Sm
antibody. A small fraction of the anti-Sm immunopre-
cipitate was analyzed for the presence of U2 and U7
snRNA by Northern blotting (Fig. 7B, lane 2), and the
remainder was analyzed for hZFP100 by Western blot-
ting. Immunoprecipitation of the nuclear extract with
the anti-Sm antibody greatly enriched the amount of
hZFP100 that was detected by Western blotting (Fig. 7A,
lane 4), but not the cross-reacting proteins. The hZFP100
was not detected in immunoprecipitates obtained with a
control monoclonal antibody (Fig. 7A, lane 3) or with
several other antibodies (data not shown). Thus, the Sm-
antibody effectively precipitates both U7 snRNA and the
hZFP100, consistent with the concept that hZFP100 is
associated with the U7 snRNP.
Because hZFP100 is associated with some of the U7
snRNPs, we sought to determine whether it might be
involved in histone pre-mRNA processing, either as a
component of an active U7 snRNP or possibly as an in-
hibitor of U7 snRNP. We attempted to deplete hZFP100
from a HeLa nuclear extract active in histone pre-mRNA
processing with the anti-hZFP100 antibody. As found
previously, significant amounts of U7 snRNA were im-
munoprecipitated by the anti-hZFP100 antibody (Fig.
8A). Analysis of the U7 snRNA remaining in the extract
showed that ∼40% of the U7 snRNA had been removed
from the extract by the antibody (Fig. 8B, top), resulting
in a twofold reduction in processing efficiency (Fig. 8B,
bottom). Treatment of the nuclear extract with a non-
specific antibody did not result in the removal of U7
snRNA and consequently did not significantly affect pro-
cessing (Fig. 8B, lane 2, top and bottom, respectively).
These results suggest that hZFP100 plays a positive role
in histone pre-mRNA processing as part of the active U7
snRNP.
hZFP100 stimulates 3-end processing of histone
mRNA in Xenopus oocytes
Because we were not able to completely abolish the in
vitro processing activity by immunodepletion with the
hZFP100 antibody, we took a different approach to show
the importance of hZFP100 in histone pre-mRNA pro-
cessing. We used an in vivo system based on injection of
histone genes into Xenopus oocytes and measuring the
efficiency of histone pre-mRNA processing. Histone pre-
mRNAs transcribed from injected mouse histone genes
are processed in Xenopus oocytes (Williams et al. 1994;
Wang et al. 1999). Moreover, Xenopus SLBP1 (xSLBP1) is
as effective as human SLBP in processing histone H2a-
614 pre-mRNA in mammalian nuclear extracts (Ingledue
et al. 2000), which shows that components of the pro-
cessing machinery in the two organisms are exchange-
able. As a prerequisite for performing the in vivo studies,
we established that hZFP100 interacts with the complex
formed between the SL RNA and xSLBP1, using the
yeast two-hybrid system (Fig. 9A, lane 2).
To determine whether expression of hZFP100 could
affect processing of histone pre-mRNA, a synthetic
mRNA encoding hZFP100 was injected into the cyto-
plasm of Xenopus oocytes, and 12 h later the mouse his-
Figure 7. The anti-Sm antibody precipitates hZFP100 from
nuclear extracts. (A) Anti-Sm antibody (lane 4) or a control an-
tibody (lane 3) was bound to protein G agarose beads and incu-
bated with 2 mg of protein from a nuclear extract from HeLa
cells. The bound proteins were resolved by gel electrophoresis,
together with a reticulocyte lysate programmed with hZFP100
DNA (lane 1) and 50 µg of the nuclear extract (lane 2). The
proteins were transferred to nitrocellulose and hZFP100 was
detected by Western blotting. (B) A portion of the same immu-
noprecipitates was used for preparation of RNA and detection of
U7 snRNA and U2 snRNA by Northern blotting.
Figure 8. Treatment of nuclear extracts with anti-hZFP100 re-
duces in vitro processing efficiency. A nuclear extract from
HeLa cells was incubated with a control antibody or the anti-
hZFP100 antibody, and the antibody complexes were adsorbed
on protein A agarose beads. (A) RNA immunoprecipitated by
either a control antibody (lane 1) or anti-hZFP100 (lane 2) was
analyzed for the presence of U7 snRNA as described in Figure 7.
(B) Equal amounts of the nuclear extract (lane 1) and the extracts
immunodepleted with the control antibody (lane 2) or the anti-
hZFP100 antibody (lane 3) were analyzed for the presence of U7
snRNA (top), and the ability to process a radiolabeled synthetic
histone H2a-614 pre-mRNA (bottom). The processed and un-
processed RNAs were resolved on an 8.5% polyacrylamide gel
and detected by autoradiography as in Figure 1B.
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tone H2a-614 gene was injected into the nucleus. Both
the pre-mRNA and the final cleavage product can be
readily and specifically detected in preparations of total
oocyte RNA by an S1 nuclease protection assay using a
probe complementary to the mouse gene (Fig. 9B; Ingle-
due et al. 2000). The size of S1 nuclease protection prod-
ucts corresponding to H2a-614 pre-mRNA (unprocessed)
and mRNA (processed) was precisely determined by us-
ing in the assay two synthetic RNAs terminating at the
appropriate sites (Fig. 9C, bottom, lanes 3 and 4, respec-
tively). Twelve hours after injection of capped and poly-
adenylated hZFP100 mRNA into the cytoplasm of stage
VI oocytes, hZFP100 was detected by Western blotting
using the anti-hZFP100 antibody (Fig. 9C, top, lane 7).
hZFP100 was present in both the nucleus and the cyto-
plasm of the oocyte (data not shown). In the oocytes
injected with the mouse H2a-614 gene and not express-
ing hZFP100, only 30% of the H2a-614 pre-mRNA was
processed (Fig. 9C, bottom, lane 6). The efficiency of 3-
end processing in the oocytes expressing hZFP100 was
>95% (Fig. 9C, bottom, lane 7), showing that hZFP100 is
involved in histone pre-mRNA processing, most likely
by associating with U7 snRNP and interacting with the
SLBP/pre-mRNA complex.
Discussion
Previously we have identified two regions of SLBP essen-
tial for 3-end processing of the H1t pre-mRNA; the RBD
located in the center of the protein and the first 20 amino
acids of the C-terminal domain. In addition to mediating
binding of SLBP to the stem–loop in the pre-mRNA, the
RBD also directly participates in recruitment of U7
snRNP to its binding site in the pre-mRNA, the HDE
(Dominski et al. 1999, 2001). This most likely occurs
through the interaction between SLBP bound to the pre-
mRNA and a protein of the U7 snRNP or another factor
that would bridge SLBP and U7snRNP. Here we have
used a novel variation of the yeast two-hybrid system
designed to clone proteins that interact with the SLBP/
stem–loop-RNA complex. A single low-abundance zinc
finger protein, hZFP100, that is associated with U7
snRNP and can stimulate histone pre-mRNA processing,
was isolated.
The RNA-supplemented two-hybrid system
can be used to clone proteins interacting with
protein–RNA complexes
In our modified version of the yeast two-hybrid system,
an RNA containing the stem–loop structure was ex-
pressed from the RNA polymerase III type promoter of
the yeast RNase P gene, that is, as originally used in the
three-hybrid system (SenGupta et al. 1996) to clone SLBP
(Wang et al. 1996a). The vast majority of the clones ob-
tained in this screen did not interact with SLBP in the
absence of the SL RNA, suggesting that the RNA is ex-
pressed in excess over SLBP in the yeast, and that all the
SLBP is present in a complex with the RNA. Interest-
ingly, several clones we isolated in a two-hybrid screen
using only SLBP as bait in the absence of the RNA (L.-X.
Zheng and W.F. Marzluff, unpubl.) interacted more
weakly with the SLBP/RNA complex than with the free
SLBP. These clones were not obtained in the modified
two-hybrid screen, further showing that all the SLBP in
the yeast is associated with the stem–loop RNA.
Using the modified two-hybrid screen, a novel zinc
finger protein, hZFP100, was cloned that interacted only
with the SLBP/RNA complex and did not interact with
SLBP mutants that are inactive in histone pre-mRNA
processing. Other proteins isolated in this screen could
be involved in subsequent steps of histone mRNA me-
Figure 9. hZFP100 stimulates processing of histone pre-mRNA in Xenopus oocytes. (A) hZFP100 interacts with the complex formed
between the SL RNA and Xenopus SLBP1 (xSLBP1). Yeast expressing the GAL4 DBD fused with xSLBP1 in the absence or presence
of the stem–loop RNA were transformed with hZFP100 and tested for the ability to grow in the presence of 10 mM 3-AT. (B) A diagram
of the S1 nuclease protection assay. The protected fragments Unproc and Proc correspond to mouse H2a-614 pre-mRNA and mRNA,
respectively. (C) Control oocytes (lane 5), oocytes injected with the H2a-614 gene (lane 6), or oocytes injected with the hZFP100 mRNA
followed 12 h later by injection with the H2a-614 gene (lane 7) were analyzed for hZFP100 by Western blotting (top). The star indicates
a Xenopus protein that cross-reacts with the anti-hZFP100 antibody. RNA was prepared from the oocytes, and the amount of processed
and unprocessed histone mRNA was measured by an S1 nuclease protection assay. Lanes 3 and 4 show the product protected by a
synthetic H2a-614 pre-mRNA and H2a-614 mRNA, respectively. The position of the undigested probe is shown in lane 1 and the probe
analyzed with yeast tRNA in lane 2.
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tabolism (transport, translation, or mRNA stability). A
similar RNA-supplemented two-hybrid system has re-
cently been used for analyzing a ternary complex formed
between Nanos, Pumilio, and its RNA target that is in-
volved in translational control of hunchback mRNA
(Sonoda and Wharton 1999). Therefore, this approach ex-
tends the repertoire of the yeast systems for analyzing
macromolecular interactions and may prove to be a gen-
eral method for cloning and studying proteins that inter-
act with protein/RNA complexes.
hZFP100 is a member of the large family of proteins
containing C2H2-type zinc fingers, first discovered in
the Xenopus transcription factor TFIIIA (Pelham and
Brown 1980). It is estimated that zinc finger proteins
may comprise 1% of all proteins encoded by the human
genome (Hoovers et al. 1992), and they represent 0.7% of
the proteins encoded in the Caenorhabditis elegans ge-
nome (Clarke and Berg 1998). Although best known as
sequence-specific DNA-binding motifs in many tran-
scription factors, the C2H2 zinc fingers also can mediate
binding of proteins to single- (Draper 1995) and double-
stranded RNAs (Finerty and Bass 1997, 1999), RNA–
DNA hybrids (Shi and Berg 1995), and to other zinc fin-
ger proteins (Mackay and Crossley 1998). Zinc finger pro-
teins of the C2H2 type have been implicated in many
aspects of cellular RNA metabolism, including pre-
mRNA splicing (Larsson et al. 1995; Davies et al. 1998)
and RNA storage (Joho et al. 1990). Some zinc finger
proteins contain as many as 37 zinc fingers (Andreazzoli
et al. 1993), and are localized exclusively in the cyto-
plasm. Clearly, the zinc finger is a protein motif that has
evolved to participate in many protein/ligand interac-
tions and may play roles in multiple aspects of mRNA
metabolism.
hZFP100 is associated with U7 snRNP
hZFP100 is present in very low concentrations, as ex-
pected for a protein that may be a component of the U7
snRNP, which is present in only about 1000 molecules
per cell. Consistent with this interpretation, only two
partial ESTs were present in the human EST database as
of June 2001, and the gene was not annotated in the
initial analysis of the human genome. Other critical
components of the histone pre-mRNA processing ma-
chinery are also likely to be low-abundance proteins. In
contrast, SLBP is required stoichiometrically for pre-
mRNA processing and is much more abundant than U7
snRNP.
Our results indicate that hZFP100 plays an important
role in histone pre-mRNA processing by interacting with
the SLBP/RNA complex. Some of the amino acids in the
RBD of SLBP critical for histone pre-mRNA processing
and interaction with hZFP100 are adjacent to amino ac-
ids critical for RNA binding (Dominski et al. 2001).
Therefore, it is possible that hZFP100 interacts with
both the SLBP and with the stem–loop in the pre-mRNA.
This interaction may position the U7 snRNP to facilitate
base-pairing between the U7 snRNA and the HDE.
Given the intimate contact of hZFP100 with the SLBP/
RNA complex, it is possible that this interaction is im-
portant for determining the position of the cleavage site
used to form histone mRNA. Steitz and co-workers have
shown that there is a stringent distance requirement be-
tween the HDE and the stem–loop (Scharl and Steitz
1994, 1996; Cho et al. 1995), consistent with a close con-
tact between the U7snRNP and the SLBP/RNA complex.
It is possible that hZFP100 may also make nonspecific
contacts with the RNA between the stem–loop and the
cleavage site, stiffening this region and in effect serving
as the molecular ruler postulated by Scharl and Steitz
(1994, 1996).
Recently another U7 snRNP protein was cloned by
isolation of the U7 snRNP from HeLa nuclear extracts
(Pillai et al. 2001). This protein, Lsm10, is a novel Sm
protein in the U7 snRNP that replaces SmD1 found in
other snRNPs (Pillai et al. 2001). It is likely that this
protein helps recognize the novel Sm site in U7 snRNA
that is critical for proper function of the U7 snRNP
(Grimm et al. 1993; Stefanovic et al. 1995). There was no
evidence of higher molecular weight polypeptides of the
size of hZFP100 in these preparations, but the U7 snRNP
prepared in this way was not active in processing (Smith
et al. 1991), suggesting that some components had been
lost during purification. It is therefore possible that
hZFP100 is a component of the active U7 snRNP and is
relatively loosely bound to the U7 snRNP particle.
Other possible functions of hZFP100 in expression
of replication-dependent histone genes
Formation of the 3 end of polyadenylated mRNAs (Con-
nelly and Manley 1988; Proudfoot 1989) is coupled to
transcription termination. We previously showed that
deletion of either the stem–loop or the HDE, required for
3-end processing of replication-dependent histone pre-
mRNAs, abolishes transcriptional termination, indicat-
ing that 3 processing of replication-dependent histone
pre-mRNAs is also mechanistically coupled to transcrip-
tion termination (Chodchoy et al. 1987). hZFP100 has
some characteristics of a DNA-binding zinc finger pro-
tein including three C-terminal C2H2 zinc fingers linked
by a seven-amino-acid sequence TGEKPY that is highly
conserved in the sequence of Krüppel-like transcription
factors. In addition, the first 200 amino acids of hZFP100
activated expression of reporter genes when fused to the
GAL4 DNA-binding domain (Z. Dominski, unpubl.).
This raises the possibility that hZFP100 might possibly
play a role in initiation or termination of transcription of
the histone genes coupling these processes to 3-end pro-
cessing of the nascent pre-mRNA. It is not uncommon
for C2H2 zinc finger proteins to play a role in both tran-
scription regulation and RNA metabolism (Ladomery
1997), and the dual function is best illustrated by known
activities of a prototype zinc finger protein, the Xenopus
TFIIIA (el Baradi and Pieler 1991; Theunissen et al.
1992). In addition to regulating transcription of the 5S
rRNA genes, this factor associates with the 5S rRNA,
thus facilitating its nuclear export and storage in the
cytoplasm (Guddat et al. 1990).
A zinc finger protein associated with U7 snRNP
GENES & DEVELOPMENT 67
Conclusions
hZFP100 is a novel protein associated with U7 snRNP
and involved in histone pre-mRNA processing. Like
many other potential proteins that affect the metabolism
of a subset of mRNAs, it is a very low abundance protein.
It is likely that there are additional low-abundance pro-
teins involved in both histone pre-mRNA processing as
well as in controlling histone mRNA metabolism, and
we are currently trying to identify additional compo-
nents in these processes.
Materials and methods
Construction of clones
C-Terminal deletion mutants of SLBP, C27, and C41 were
constructed by PCR amplification of the SLBP cDNA encoding
amino acids 1–243 and 1–229, respectively (Fig. 1A). The pGBT/
SLBP/SLWT plasmid used as the bait to isolate proteins inter-
acting with the SLBP/RNA complex was constructed in two
steps. First, SLBP C27 was subcloned into a pGBT9 derivative
containing NcoI and SacI sites in the multiple cloning site
(kindly provided by Yue Xiong, UNC), resulting in the pGBT/
SLBP plasmid. This plasmid, expressing SLBP C27 fused in
frame to the GAL4 DNA-binding domain (DBD), was cleaved at
the unique AatII site and blunt-end-ligated to a 534-nt SpeI
fragment of the polIII/SLWT plasmid (Wang et al. 1996a). The
SpeI fragment encompasses the entire transcription unit, which
allows efficient expression of a nuclear RNA containing the
histone stem–loop (SL) structure from the RNA Pol III specific
promoter of the yeast RNase P gene. The resulting pGBT/SLBP/
SLWT plasmid is thus capable of expressing both components of
the SLBP/SL complex. The deletions and modifications of SLBP,
Xenopus SLBP1 (xSLBP1), and hZFP100 were constructed by
standard technology. All clones were sequenced in the Sequenc-
ing Facility at UNC, Chapel Hill. Details of each construct are
available on request.
The RNA-supplemented two-hybrid screen
Yeast transformation, minipreparation of the yeast DNA, and
rescue of the library plasmid were carried out according to stan-
dard yeast protocols, as described elsewhere (Dominski and
Marzluff 2001). The RNA-supplemented two-hybrid screen was
performed in the yeast strain CG-1945 transformed with the
pGBT/SLBP/SLWT bait plasmid (TRP1 selection). The yeast cells
transformed with the HeLa cDNA library (LEU2 selection) were
plated on synthetic defined (SD) medium lacking tryptophan,
leucine, and histidine, supplemented with increasing concen-
trations of 3-aminotriazole (3-AT). For analysis of the interac-
tion between selected library clones and various SLBP variants
in the presence and absence of the SL RNA, the yeast transfor-
mants were initially grown on plates containing histidine and
subsequently scraped and resuspended in sterile water to a den-
sity of ∼106 cells/mL. The cell suspension (5–10 µL) was spotted
on selective SD medium lacking histidine, supplemented with
various concentrations of 3-AT. The same amount of the cell
suspension was also applied to medium containing histidine to
control for growth under nonselective conditions. After incuba-
tion at 27°C for 2 d, the plates were photographed using a video
camera, and the images were processed by NIH Image software
(National Institutes of Health).
Liquid assay for -galactosidase activity
Expression of the LacZ reporter gene was determined by quali-
tative analysis of -galactosidase activity according to a modi-
fied version of the liquid assay, as previously described (Dom-
inski and Marzluff 2001). For illustrations, a portion of the cell
suspension was spotted on a white membrane, dried, and pho-
tographed using a video camera. The images were processed by
NIH Image software (National Institutes of Health).
Expression and purification of recombinant SLBP
The wild-type and deletion mutants of SLBP were expressed in
Sf9 insect cells using the baculovirus expression system, and
the His-tagged proteins were purified as previously described
(Dominski et al. 1999, 2001).
In vitro synthesis and labeling of RNA
In vitro 3-end processing was carried out using 86-nt pre-
mRNAs containing the stem–loop structure and the U7 binding
site from either the mouse H2a-614 or H1t pre-mRNAs. The
sequences of both RNAs and methods for their synthesis and
labeling have been described previously (Dominski et al. 1995,
1999; Marzluff et al. 1997). Capped and polyadenylated mRNA
encoding hZFP100 used for oocyte injection was synthesized by
SP6 transcription of the pSP64T/hZFP100 plasmid linearized
with PvuII, as described (Wang et al. 1999). The identity of the
mouse histone H2a-614 mRNA and pre-mRNA expressed in
Xenopus oocytes was confirmed by using a synthetic RNA end-
ing either precisely at the cleavage site or 104 nt further down-
stream, respectively. The two RNAs were generated by T7 tran-
scription of PCR amplification products containing the T7 pro-
moter and the mouse histone H2a-614 gene.
Preparation of nuclear extracts and 3-end processing
Preparation of nuclear extracts from both mouse myeloma and
human HeLa cells, immunodepletion of SLBP and 3-end pro-
cessing of histone pre-mRNA were performed as previously de-
scribed (Dominski et al. 1995, 1999; Marzluff et al. 1997). HeLa
cells were provided by the National Cell Culture Center (Min-
neapolis, MN).
Generation and affinity purification
of anti-hZFP100 antibodies
Rabbits were injected at Pocono Farms (Candenensis, PA) with
a KLH-conjugated C-terminal peptide corresponding to the last
18 amino acids of hZFP100. The serum was purified using the
C-terminal peptide coupled to an agarose support using the Sul-
foLink kit (Pierce). The affinity-purified polyclonal antibody
(average protein concentration of 0.5 µg/µL) was eluted from the
column with 100 mM Glycine-HCl (pH 2.5) and immediately
neutralized.
In vitro synthesis of hZFP100
hZFP100 was synthesized in the rabbit reticulocyte extract us-
ing the coupled transcription and translation system (TnT) from
Promega (Madison, WI) according to the manufacturer’s proto-
col. Each reaction (50 µL total volume) contained 2.5 µg of su-
percoiled pSP64T/hZFP100 DNA and was carried out in the
absence of labeled amino acids. When required, the TnT reac-
tion was supplemented with 35S-methionine (NEN), and unla-
beled methionine was omitted.
Dominski et al.
68 GENES & DEVELOPMENT
Western blotting
Proteins were resolved by electrophoresis on 12% SDS poly-
acrylamide gels, transferred to nitrocellulose, and analyzed by
Western blotting as previously described (Whitfield et al. 2000).
Immunoprecipitation of processing complexes
Processing complexes containing the U7 snRNP were formed
on H2a-614 pre-mRNA in a HeLa nuclear extract and immuno-
precipitated as described (Dominski et al. 1999, 2001). Each re-
action contained 25 ng of the pre-mRNA substrate, 75 µL of the
nuclear extract, and 20 mM EDTA (pH 8) in a total volume of
100 µL. The samples were incubated at 22°C for 5 min to allow
formation of the processing complexes, supplemented with 5 µg
of affinity-purified antibody directed against either SLBP or
hZFP100, and incubated at 4°C with rotation for 1 h. Antibody–
antigen complexes were adsorbed on 20 µL of protein A agarose
beads (GIBCO BRL), and RNA was prepared from the immuno-
precipitate. The RNA was resolved on an 8.5% polyacrylamide/
7M urea gel and transferred to Hybond-N+ synthetic membrane
(Amersham), and the U7 snRNA was detected by hybridization
with a riboprobe complementary to human U7 snRNA. Prior to
phenol extraction, 0.5 ng of a synthetic mouse U7 snRNA was
added to each sample to monitor the efficiency of RNA recovery
and hybridization with the anti-U7 probe. This RNA hybridizes
with the human U7 snRNA probe, and contains additional se-
quences on both ends of the U7 snRNA sequence, thus migrat-
ing significantly slower than the endogenous human U7 snRNA
(Dominski et al. 1999, 2001). The specificity of U7 snRNA pre-
cipitation was determined by reblotting the same membrane
with a probe complementary to human U1 snRNA or U2
snRNA (Bond 1988).
Immunoprecipitation of U7 snRNP
The U7 snRNP was directly immunoprecipitated from 100 µL
of HeLa nuclear extract by addition of either 25 µg of the anti-
Sm monoclonal antibody (Lerner and Steitz 1979) or 5 µg of
anti-hZFP100 antibody. The samples containing the nuclear ex-
tract and the antibody were rotated at 4°C for 1 h. The immu-
nocomplexes were absorbed on protein A agarose beads and fur-
ther processed as described above for analysis of U7 snRNA.
Detection of hZFP100 in anti-Sm precipitate
For immunoprecipitation of anti-Sm reactive snRNPs, a 500-µL
aliquot of mouse ascitic fluid containing the monoclonal anti-
Sm antibody Y-12 (Lerner et al. 1981) was rotated at 4°C for 2 h
with 50 µL of protein G agarose beads (GIBCO BRL) in the
presence of 100 mM Tris-HCl (pH 7). The beads were collected,
washed several times with buffer D (20 mM HEPES-KOH at pH
7.9, 100 mM KCl, 0.5 mM DTT, 0.2 mM EDTA at pH 8.0, 20%
glycerol), and mixed with 250 µL of HeLa nuclear extract. After
rotation at 4°C for 2 h, the supernatant was removed and the
beads were washed several times with buffer D/0.1% NP-40 and
tested for the presence of both U7 snRNA by Northern blotting
(20% of the beads) and hZFP100 by Western blotting (80% of the
beads).
Injection of Xenopus oocytes
Stage V–VI oocytes were injected in the cytoplasm with 30 nL of
a solution containing 1.5 ng of the in vitro synthesized capped
and polyadenylated mRNA encoding hZFP100. Twelve hours
after injection of the synthetic mRNA, the nucleus of each
healthy oocyte was injected with 15 nL of a solution containing
blue dextran and 750 pg of plasmid DNA containing the mouse
H2a-614 gene. The oocytes were incubated for an additional 12
h, and the total RNA for each experiment was isolated from a
pool of 30 oocytes. The histone mRNAs were detected by S1
nuclease mapping as previously described (Ingledue et al. 2000).
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